These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 14505637)
1. Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors. Ogawa AK; Willoughby CA; Bergeron R; Ellsworth KP; Geissler WM; Myers RW; Yao J; Harris G; Chapman KT Bioorg Med Chem Lett; 2003 Oct; 13(20):3405-8. PubMed ID: 14505637 [TBL] [Abstract][Full Text] [Related]
2. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models. Furukawa S; Murakami K; Nishikawa M; Nakayama O; Hino M J Antibiot (Tokyo); 2005 Aug; 58(8):503-6. PubMed ID: 16266121 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro ADME profiling and in vivo pharmacological evaluation of novel glycogen phosphorylase inhibitors. Miao GX; Wang YD; Yan ZW; Zhang LY Bioorg Med Chem Lett; 2020 Jul; 30(14):127117. PubMed ID: 32527535 [TBL] [Abstract][Full Text] [Related]
4. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition. Goyard D; Kónya B; Chajistamatiou AS; Chrysina ED; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Somsák L; Docsa T; Gergely P; Praly JP; Azay-Milhau J; Vidal S Eur J Med Chem; 2016 Jan; 108():444-454. PubMed ID: 26708111 [TBL] [Abstract][Full Text] [Related]
5. Glycogen phosphorylase inhibitors. Henke BR; Sparks SM Mini Rev Med Chem; 2006 Aug; 6(8):845-57. PubMed ID: 16918491 [TBL] [Abstract][Full Text] [Related]
6. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity. Wang Y; Yan Z; Guo Y; Zhang L Future Med Chem; 2021 May; 13(10):897-909. PubMed ID: 33906369 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice. Mackay P; Ynddal L; Andersen JV; McCormack JG Diabetes Obes Metab; 2003 Nov; 5(6):397-407. PubMed ID: 14617225 [TBL] [Abstract][Full Text] [Related]
8. Hypoglycemic effects and constituents of the barks of Cyclocarya paliurus and their inhibiting activities to glucosidase and glycogen phosphorylase. Li S; Li J; Guan XL; Li J; Deng SP; Li LQ; Tang MT; Huang JG; Chen ZZ; Yang RY Fitoterapia; 2011 Oct; 82(7):1081-5. PubMed ID: 21784137 [TBL] [Abstract][Full Text] [Related]
10. Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Thomson SA; Banker P; Bickett DM; Boucheron JA; Carter HL; Clancy DC; Cooper JP; Dickerson SH; Garrido DM; Nolte RT; Peat AJ; Sheckler LR; Sparks SM; Tavares FX; Wang L; Wang TY; Weiel JE Bioorg Med Chem Lett; 2009 Feb; 19(4):1177-82. PubMed ID: 19138846 [TBL] [Abstract][Full Text] [Related]
11. New inhibitors of glycogen phosphorylase as potential antidiabetic agents. Somsák L; Czifrák K; Tóth M; Bokor E; Chrysina ED; Alexacou KM; Hayes JM; Tiraidis C; Lazoura E; Leonidas DD; Zographos SE; Oikonomakos NG Curr Med Chem; 2008; 15(28):2933-83. PubMed ID: 19075645 [TBL] [Abstract][Full Text] [Related]
12. Glycogen phosphorylase inhibitors: a patent review (2013 - 2015). Donnier-Maréchal M; Vidal S Expert Opin Ther Pat; 2016; 26(2):199-212. PubMed ID: 26666989 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in the allosteric inhibition of glycogen phosphorylase. Loughlin WA Mini Rev Med Chem; 2010 Oct; 10(12):1139-55. PubMed ID: 20716052 [TBL] [Abstract][Full Text] [Related]
14. Computation as a tool for glycogen phosphorylase inhibitor design. Hayes JM; Leonidas DD Mini Rev Med Chem; 2010 Oct; 10(12):1156-74. PubMed ID: 20716053 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases. Zhang L; Chen J; Gong Y; Liu J; Zhang L; Hua W; Sun H Chem Biodivers; 2009 Jun; 6(6):864-74. PubMed ID: 19551727 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogenolysis towards antidiabetic and other therapies. Somsák L Mini Rev Med Chem; 2010 Oct; 10(12):1091-2. PubMed ID: 20716057 [No Abstract] [Full Text] [Related]
19. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site. Kristiansen M; Andersen B; Iversen LF; Westergaard N J Med Chem; 2004 Jul; 47(14):3537-45. PubMed ID: 15214781 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and glycogen phosphorylase inhibitor activity of functionalized 1,4-benzodioxanes. Czakó Z; Docsa T; Gergely P; Juhász L; Antus S Pharmazie; 2010 Apr; 65(4):235-8. PubMed ID: 20432616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]